DK1032579T3 - Carbohydratderivater - Google Patents
CarbohydratderivaterInfo
- Publication number
- DK1032579T3 DK1032579T3 DK98958248T DK98958248T DK1032579T3 DK 1032579 T3 DK1032579 T3 DK 1032579T3 DK 98958248 T DK98958248 T DK 98958248T DK 98958248 T DK98958248 T DK 98958248T DK 1032579 T3 DK1032579 T3 DK 1032579T3
- Authority
- DK
- Denmark
- Prior art keywords
- carbohydrate derivatives
- carbohydrate
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97203613 | 1997-11-19 | ||
PCT/EP1998/007518 WO1999025720A1 (en) | 1997-11-19 | 1998-11-16 | Carbohydrate derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1032579T3 true DK1032579T3 (da) | 2003-08-25 |
Family
ID=8228942
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98958248T DK1032579T3 (da) | 1997-11-19 | 1998-11-16 | Carbohydratderivater |
Country Status (34)
Country | Link |
---|---|
US (1) | US6174863B1 (da) |
EP (1) | EP1032579B1 (da) |
JP (1) | JP4364959B2 (da) |
KR (1) | KR100518497B1 (da) |
CN (1) | CN1177855C (da) |
AR (1) | AR017640A1 (da) |
AT (1) | ATE239030T1 (da) |
AU (1) | AU746959B2 (da) |
BR (1) | BRPI9804699B1 (da) |
CA (1) | CA2253113C (da) |
CO (1) | CO4990974A1 (da) |
CZ (1) | CZ293639B6 (da) |
DE (1) | DE69814140T2 (da) |
DK (1) | DK1032579T3 (da) |
EE (1) | EE04348B1 (da) |
ES (1) | ES2198081T3 (da) |
HK (1) | HK1028406A1 (da) |
HU (1) | HU226685B1 (da) |
ID (1) | ID21287A (da) |
IL (1) | IL126893A (da) |
IS (1) | IS2527B (da) |
NO (1) | NO310723B1 (da) |
NZ (1) | NZ332834A (da) |
PE (1) | PE134799A1 (da) |
PL (1) | PL188229B1 (da) |
PT (1) | PT1032579E (da) |
RU (1) | RU2210573C2 (da) |
SG (1) | SG72889A1 (da) |
SK (1) | SK284134B6 (da) |
TR (1) | TR199802372A2 (da) |
TW (1) | TW448180B (da) |
UA (1) | UA49089C2 (da) |
WO (1) | WO1999025720A1 (da) |
ZA (1) | ZA9810559B (da) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI289566B (en) * | 1999-12-07 | 2007-11-11 | N.V.Organon | Antithrombotic compound |
EP1353556A4 (en) * | 2001-01-23 | 2009-09-09 | Massachusetts Inst Technology | SYNTHESIS OF HEPARIN AND OTHER GLYCOSAMINOGLYCANS IN SOLID PHASE AND SOLUTION PHASE |
AU2003302238A1 (en) | 2002-12-03 | 2004-06-23 | Axys Pharmaceuticals, Inc. | 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors |
CN1317287C (zh) * | 2003-04-18 | 2007-05-23 | 山东大学 | 一种多硫酸寡糖及其制备方法 |
TWI426080B (zh) * | 2004-03-04 | 2014-02-11 | Progen Pharmaceuticals Ltd | 硫酸化寡醣衍生物 |
JP2011522805A (ja) | 2008-05-30 | 2011-08-04 | モメンタ ファーマシューティカルズ インコーポレイテッド | 糖構造ならびにそのような構造を作製および使用する方法 |
WO2010029552A1 (en) * | 2008-09-10 | 2010-03-18 | Transpharma Medical Ltd. | Transdermal delivery of oligosaccharides |
EP2464668B1 (en) | 2009-07-31 | 2022-12-07 | Reliable Biopharmaceutical Corporation | Process for preparing fondaparinux sodium and intermediates useful in the synthesis thereof |
US8420790B2 (en) | 2009-10-30 | 2013-04-16 | Reliable Biopharmaceutical Corporation | Efficient and scalable process for the manufacture of Fondaparinux sodium |
EP2721044B1 (en) * | 2011-06-17 | 2015-11-18 | Carbomimetics | Synthetic pentasaccharides having short half-life and high activity |
EP2578594A1 (en) | 2011-10-04 | 2013-04-10 | Sanofi | Process of preparation of L-iduronic acid comprising a decarboxylation/intramolecular cyclisation tandem reaction |
US9873712B2 (en) | 2014-10-03 | 2018-01-23 | Amphastar Pharmaceuticals, Inc. | Method of purifying idraparinux sodium |
CN109134554B (zh) * | 2017-06-15 | 2021-09-28 | 南京正大天晴制药有限公司 | 抗凝血的五糖类化合物及其制备方法和医药用途 |
CN109134555B (zh) * | 2017-06-15 | 2021-09-28 | 南京正大天晴制药有限公司 | 抗凝血的五糖类化合物及其制备方法和医药用途 |
CN109134553B (zh) * | 2017-06-15 | 2021-09-28 | 南京正大天晴制药有限公司 | 抗凝血的五糖类化合物及其制备方法和医药用途 |
WO2021043631A1 (en) | 2019-09-02 | 2021-03-11 | Hepoligo Solutions Aps | Intermediates useful for preparing iduronic acid containing di- and polysaccharides |
WO2021211441A1 (en) * | 2020-04-13 | 2021-10-21 | The Board Of Regents Of The University Of Oklahoma | Modified sugar polymers with low anticoagulant activity and therapeutic activity |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0300099A1 (en) * | 1987-07-20 | 1989-01-25 | Akzo N.V. | New pentasaccharides |
IE64378B1 (en) * | 1990-04-23 | 1995-07-26 | Akzo Nv | Carbohydrate derivatives comprising a trisaccharide unit |
IL102758A (en) * | 1991-08-23 | 1997-03-18 | Akzo Nv | Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them |
-
1998
- 1998-11-04 IL IL12689398A patent/IL126893A/xx not_active IP Right Cessation
- 1998-11-09 CA CA002253113A patent/CA2253113C/en not_active Expired - Fee Related
- 1998-11-16 WO PCT/EP1998/007518 patent/WO1999025720A1/en active IP Right Grant
- 1998-11-16 EE EEP200000301A patent/EE04348B1/xx unknown
- 1998-11-16 EP EP98958248A patent/EP1032579B1/en not_active Expired - Lifetime
- 1998-11-16 DK DK98958248T patent/DK1032579T3/da active
- 1998-11-16 SK SK736-2000A patent/SK284134B6/sk not_active IP Right Cessation
- 1998-11-16 AT AT98958248T patent/ATE239030T1/de active
- 1998-11-16 UA UA2000052804A patent/UA49089C2/uk unknown
- 1998-11-16 DE DE69814140T patent/DE69814140T2/de not_active Expired - Lifetime
- 1998-11-16 ES ES98958248T patent/ES2198081T3/es not_active Expired - Lifetime
- 1998-11-16 KR KR10-1998-0049021A patent/KR100518497B1/ko not_active IP Right Cessation
- 1998-11-16 PT PT98958248T patent/PT1032579E/pt unknown
- 1998-11-17 NZ NZ332834A patent/NZ332834A/xx not_active IP Right Cessation
- 1998-11-18 HU HU9802663A patent/HU226685B1/hu not_active IP Right Cessation
- 1998-11-18 ID IDP981506A patent/ID21287A/id unknown
- 1998-11-18 SG SG1998004851A patent/SG72889A1/en unknown
- 1998-11-18 NO NO19985365A patent/NO310723B1/no not_active IP Right Cessation
- 1998-11-18 US US09/193,901 patent/US6174863B1/en not_active Expired - Lifetime
- 1998-11-18 AU AU93242/98A patent/AU746959B2/en not_active Ceased
- 1998-11-18 RU RU98120933/04A patent/RU2210573C2/ru active
- 1998-11-18 JP JP32768298A patent/JP4364959B2/ja not_active Expired - Fee Related
- 1998-11-18 BR BRPI9804699A patent/BRPI9804699B1/pt not_active IP Right Cessation
- 1998-11-18 ZA ZA9810559A patent/ZA9810559B/xx unknown
- 1998-11-18 PE PE1998001123A patent/PE134799A1/es not_active IP Right Cessation
- 1998-11-18 CN CNB981224148A patent/CN1177855C/zh not_active Expired - Fee Related
- 1998-11-19 CO CO98068215A patent/CO4990974A1/es unknown
- 1998-11-19 AR ARP980105862A patent/AR017640A1/es active IP Right Grant
- 1998-11-19 PL PL98329789A patent/PL188229B1/pl unknown
- 1998-11-19 TR TR1998/02372A patent/TR199802372A2/xx unknown
- 1998-11-19 CZ CZ19983761A patent/CZ293639B6/cs not_active IP Right Cessation
- 1998-11-23 TW TW087119398A patent/TW448180B/zh not_active IP Right Cessation
-
2000
- 2000-05-09 IS IS5485A patent/IS2527B/is unknown
- 2000-12-07 HK HK00107848A patent/HK1028406A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE260243T1 (de) | N-aroylphenylalaninderivate | |
ATE235220T1 (de) | Resorcinderivate | |
ID22781A (id) | Turunan-turunan nikotinamida | |
DE69817186D1 (de) | Diaminorhodamin-derivate | |
DE69839398D1 (de) | Pyridinderivate | |
ATE310742T1 (de) | C-4ß-SUBSTITUTIERTE MACROLID-DERIVATE | |
PT915088E (pt) | Derivados de d-prolina | |
NO20000231D0 (no) | Dolastatin-15-derivater | |
ATE255098T1 (de) | Substituierte chromanderivate | |
PT1027362E (pt) | Derivados de cetolidos 2-halogeno-6-o-substituidos | |
PT1003719E (pt) | Derivados microbicidas de n-sulfonil-glicinalquiniloxifenemetilamida | |
ATE239030T1 (de) | Kohlenhydrat-derivate | |
DE69841086D1 (de) | 5-Deoxy-Cytidin-Derivate | |
ATE255099T1 (de) | Substituierte chromanderivate | |
ATE231508T1 (de) | Azyklische nukleosidderivate | |
DK0818459T3 (da) | Carbonhydrat-derivater | |
DE69829682D1 (de) | Cis-disubstituierte aminocycloalkyl-pyrrolidin-derivate | |
DE69828780D1 (de) | Amidinocamptpthecin-derivate | |
NO981495D0 (no) | Phenoxymetylpiperidin-derivater | |
DK0966437T3 (da) | 5-Aroylnaphthalenderivater | |
DK1015447T3 (da) | Piperidinylmethyloxazolidinonderivat | |
BR9605988A (pt) | Derivados da carboestirila | |
NO993562L (no) | Gemcitabine derivater | |
DK0926243T3 (da) | Riboflavinglucosid | |
ATA69896A (de) | 3-methylimino-3-cephemderivate 3-methylimino-3-cephemderivate |